🇺🇸 MK-3102 in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 5

Most-reported reactions

1. Altered State Of Consciousness — 1 report (20%)
2. Blood Glucose Increased — 1 report (20%)
3. Dyspnoea — 1 report (20%)
4. Non-Cardiac Chest Pain — 1 report (20%)
5. Psoriasis — 1 report (20%)

Source database →

Frequently asked questions

Is MK-3102 approved in United States?

MK-3102 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for MK-3102 in United States?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.